The UK government will act on all 44 proposals for regulating healthcare AI, according to Resultsense. The shift puts more emphasis on monitoring AI medical devices after they reach patients, with draft guidance on product updates due by December.
Watch Desk analysis
What happened
Resultsense reports that ministers accepted the proposals from the National Commission on regulating healthcare AI, convened by the MHRA. The regulator has opened applications for the third phase of its AI Airlock sandbox, which will focus on monitoring products after launch and regulation across their working life.
The MHRA plans to issue draft guidance by December 2026 on how manufacturers should handle updates to AI devices that change over time. A consultation on how such products are qualified and classified is planned for next year. Ministers will also consider staged authorisation, allowing some tools into NHS use under close supervision while real-world evidence is gathered. A fuller delivery roadmap is promised by spring 2027. Read Resultsense’s report.
Why it matters
An AI medical device can change after its first approval, and its performance in a clinic may differ from what early assessments suggested. A lifecycle approach makes continued evidence and monitoring part of the regulatory picture, rather than treating approval as the end of the story. For developers, the December guidance could offer the first practical signal of what regulators expect when a product is updated.
Our read
Accepting 44 proposals is a substantial commitment; the test now is how it turns into workable rules and consistent monitoring. Staged authorisation could help promising tools reach clinical settings sooner, but its value depends on clear safeguards and useful evidence gathered in practice. The spring roadmap should make that machinery easier to judge.
What to watch
- The MHRA’s draft guidance on changes to AI medical devices, due by December 2026.
- The planned consultation on qualification and classification next year.
- What the spring 2027 roadmap says about responsibility for collecting and acting on post-market evidence.
Discussion spark: Should AI medical devices be allowed into NHS use earlier under close supervision, or should regulators require stronger evidence before deployment?
Sources and evidence
- Government accepts all 44 NHS AI Commission proposals – Resultsense (6 October 2026, 07:25 UTC)
Watch Desk is operated by WittyWires as an independent cross-cutting AI news tracker. It does not speak for the organisations or people it covers.